Wag! Group Co. Announces Sale of Furscription to MWI Veterinary Supply Co.
Wag! Group Co. (Nasdaq: PET) has announced and completed the sale of its Furscription business to MWI Veterinary Supply Co. The transaction, which closed on July 14th, 2025, includes the Furscription brand, e-prescribing technology, related assets, and the transfer of four Wag! employees to MWI.
The cash proceeds from the sale will be used to pay down outstanding debt. This strategic move aligns with Wag!'s ongoing efforts to strengthen its financial position and focus on core service and wellness offerings. For MWI, the acquisition enhances their tech-enabled solutions portfolio, providing veterinary practices with improved prescription management capabilities.
[ "Strategic debt reduction through sale proceeds", "Streamlined business focus on core services and wellness offerings", "Successful exit of non-core business unit", "Alignment with ongoing strategic review to enhance shareholder value" ]Wag! Group Co. (Nasdaq: PET) ha annunciato e completato la vendita del suo business Furscription a MWI Veterinary Supply Co. La transazione, conclusa il 14 luglio 2025, include il marchio Furscription, la tecnologia di prescrizione elettronica, i relativi asset e il trasferimento di quattro dipendenti Wag! a MWI.
Il ricavato in contanti dalla vendita sar脿 utilizzato per ridurre il debito residuo. Questa mossa strategica 猫 in linea con gli sforzi continui di Wag! per rafforzare la propria posizione finanziaria e concentrarsi sui servizi principali e sulle offerte di benessere. Per MWI, l'acquisizione arricchisce il portafoglio di soluzioni tecnologiche, offrendo alle cliniche veterinarie una migliore gestione delle prescrizioni.
- Riduzione strategica del debito tramite i proventi della vendita
- Focalizzazione semplificata sul core business e sulle offerte di benessere
- Uscita di successo da un'unit脿 aziendale non centrale
- Allineamento con la revisione strategica in corso per aumentare il valore per gli azionisti
Wag! Group Co. (Nasdaq: PET) ha anunciado y completado la venta de su negocio Furscription a MWI Veterinary Supply Co. La transacci贸n, cerrada el 14 de julio de 2025, incluye la marca Furscription, la tecnolog铆a de prescripci贸n electr贸nica, los activos relacionados y la transferencia de cuatro empleados de Wag! a MWI.
Los ingresos en efectivo de la venta se utilizar谩n para reducir la deuda pendiente. Este movimiento estrat茅gico se alinea con los esfuerzos continuos de Wag! para fortalecer su posici贸n financiera y enfocarse en sus servicios principales y ofertas de bienestar. Para MWI, la adquisici贸n mejora su portafolio de soluciones tecnol贸gicas, proporcionando a las cl铆nicas veterinarias mejores capacidades de gesti贸n de prescripciones.
- Reducci贸n estrat茅gica de deuda mediante los ingresos de la venta
- Enfoque simplificado en servicios principales y ofertas de bienestar
- Salida exitosa de una unidad de negocio no central
- Alineaci贸n con la revisi贸n estrat茅gica en curso para aumentar el valor para los accionistas
Wag! Group Co. (Nasdaq: PET)电� Furscription 靷梾攵�毳� MWI Veterinary Supply Co鞐� 毵り皝頄堧嫟瓿� 氚滍憸頃橁碃 瓯半灅毳� 鞕勲頄堨姷雼堧嫟. 鞚� 瓯半灅电� 2025雲� 7鞗� 14鞚检棎 膦呺霅橃棃鞙茧┌, Furscription 敫岆灉霌�, 鞝勳瀽 觳橂癌 旮办垹, 甏�霠� 鞛愳偘 氚� Wag! 歆侅洂 4氇呾潣 MWI搿滌潣 鞚挫爠鞚� 韽暔霅╇媹雼�.
毵り皝鞙茧 氚滌儩頃� 順勱笀 靾橃澋旮堨潃 氙胳旮� 攵�毂� 靸來櫂鞐� 靷毄霅� 鞓堨爼鞛呺媹雼�. 鞚� 鞝勲灥鞝� 臁办箻电� Wag!臧� 鞛 瓯挫爠靹膘潉 臧曧檾頃橁碃 頃奠嫭 靹滊箘鞀� 氚� 鞗半媹鞀� 鞝滉车鞐� 歆戩頃橂牑电� 歆�靻嶌爜鞚� 雲鸽牓瓿� 攵�頃╉暕雼堧嫟. MWI鞐愱矊电� 鞚措矆 鞚胳垬臧� 旮办垹 旮半皹 靻旊（靺� 韽姼韽措Μ鞓るゼ 臧曧檾頃橃棳 靾橃潣 歆勲靻岇棎 頄レ儊霅� 觳橂癌 甏�毽� 旮半姤鞚� 鞝滉车頃樀鐢 瓿勱赴臧� 霅╇媹雼�.
- 毵り皝 靾橃澋鞚� 韱淀暅 鞝勲灥鞝� 攵�毂� 臧愳稌
- 頃奠嫭 靹滊箘鞀� 氚� 鞗半媹鞀� 鞝滉车鞐� 歆戩
- 牍勴暤鞁� 靷梾攵� 靹标车鞝� 毵り皝
- 欤检＜ 臧�旃� 頄レ儊鞚� 鞙勴暅 歆�靻嶌爜 鞝勲灥 瓴�韱犾檧鞚� 鞚检箻
Wag! Group Co. (Nasdaq : PET) a annonc茅 et finalis茅 la vente de sa division Furscription 脿 MWI Veterinary Supply Co. La transaction, conclue le 14 juillet 2025, comprend la marque Furscription, la technologie de prescription 茅lectronique, les actifs associ茅s ainsi que le transfert de quatre employ茅s de Wag! vers MWI.
Les liquidit茅s issues de la vente seront utilis茅es pour rembourser la dette en cours. Cette d茅cision strat茅gique s'inscrit dans les efforts continus de Wag! pour renforcer sa position financi猫re et se concentrer sur ses services principaux et ses offres de bien-锚tre. Pour MWI, cette acquisition enrichit leur portefeuille de solutions technologiques, offrant aux cabinets v茅t茅rinaires une meilleure gestion des prescriptions.
- R茅duction strat茅gique de la dette gr芒ce aux produits de la vente
- Concentration simplifi茅e sur les services principaux et les offres de bien-锚tre
- Sortie r茅ussie d'une unit茅 commerciale non essentielle
- Alignement avec la revue strat茅gique en cours pour accro卯tre la valeur pour les actionnaires
Wag! Group Co. (Nasdaq: PET) hat den Verkauf seines Furscription-Gesch盲fts an MWI Veterinary Supply Co angek眉ndigt und abgeschlossen. Die Transaktion, die am 14. Juli 2025 abgeschlossen wurde, umfasst die Marke Furscription, die E-Rezept-Technologie, zugeh枚rige Verm枚genswerte sowie die 脺bernahme von vier Wag!-Mitarbeitern durch MWI.
Die Erl枚se aus dem Verkauf werden zur Tilgung ausstehender Schulden verwendet. Dieser strategische Schritt steht im Einklang mit den laufenden Bem眉hungen von Wag!, die finanzielle Position zu st盲rken und sich auf Kernservices und Wellness-Angebote zu konzentrieren. F眉r MWI erweitert die 脺bernahme das Portfolio technologiegest眉tzter L枚sungen und bietet Tierarztpraxen verbesserte M枚glichkeiten im Rezeptmanagement.
- Strategische Schuldenreduzierung durch Verkaufserl枚se
- Fokussierung auf Kernservices und Wellness-Angebote
- Erfolgreicher Ausstieg aus einem nicht zum Kerngesch盲ft geh枚renden Bereich
- Ausrichtung an der laufenden strategischen 脺berpr眉fung zur Steigerung des Aktion盲rswerts
- None.
- Divestment of technology asset and potential future revenue stream
- Loss of four employees to acquiring company
- Reduction in business diversification
Insights
Wag! sells Furscription to MWI, using proceeds to reduce debt while refocusing on core business as part of strategic review.
Wag! Group has completed the sale of its Furscription business to MWI Veterinary Supply, a transaction that carries several strategic implications. The deal, which closed on July 14th, included the transfer of Furscription's brand, e-prescribing technology, related assets, and four employees to MWI.
The cash considerations from this transaction will be directed toward paying down outstanding debt, strengthening Wag!'s balance sheet. While the specific sale amount wasn't disclosed, this debt reduction represents a tangible financial benefit that could improve the company's financial flexibility and reduce interest expenses.
This divestiture appears to be part of a broader strategic review initiated by Wag! and its Board to enhance shareholder value. The company is explicitly refocusing on its core offerings of services and wellness, suggesting a more streamlined business approach rather than diversification.
For MWI, Furscription complements their existing technology-enabled solutions for veterinary practices, potentially creating synergies that Wag! might have struggled to develop independently. The e-prescribing platform aims to simplify prescription requests for veterinary staff, addressing operational inefficiencies in veterinary practices.
This transaction represents classic corporate restructuring鈥攕hedding non-core assets to strengthen the balance sheet and sharpen strategic focus. The move suggests Wag! is prioritizing financial stability and operational focus over maintaining a broader portfolio of pet-related businesses, which could improve long-term competitiveness in their primary market segments.
Transaction Reflects the Board鈥檚 Ongoing Strategy to Maximize Shareholder Value
SAN FRANCISCO, July 15, 2025 (GLOBE NEWSWIRE) -- Wag! Group Co. (鈥�Wag!鈥�; Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, announced today that it has simultaneously entered into a definitive agreement (the 鈥�Agreement鈥�) and completed the sale of its Furscription business to MWI Veterinary Supply Co. (鈥�MWI鈥�), a leading global provider of veterinary products, services and solutions.
Under the terms of the Agreement, Furscription was sold to MWI for cash considerations. The transaction includes the Furscription brand, e-prescribing technology and related assets. In addition, four Wag! employees are joining MWI as part of the transaction, which closed on July 14th, 2025. Proceeds from the transaction will be used to pay down outstanding debt.
鈥淲e鈥檙e very proud of what we built with Furscription and feel fortunate to have partnered with such a talented and dedicated team,鈥� said Garrett Smallwood, CEO and Chairman of Wag!. 鈥淲e are confident that Furscription is in great hands with MWI, who we believe is well-positioned to bring the product to market and realize its full potential.鈥�
鈥淭his transaction marks an important step in our ongoing efforts to strengthen our financial position and streamline our focus on our core offerings of services and wellness. In partnership with our Board, it also reflects the meaningful progress we鈥檙e making in our strategic review as we continue to pursue opportunities to enhance shareholder value and optimize our capital structure.鈥�
Steve Shell, SVP & President, MWI, commented: 鈥淎s veterinary practices face new pressures, we remain focused on providing them with access to the solutions they need to improve the client experience, optimize operations and grow revenue 鈥� all while continuing to deliver high-quality care. Furscription builds upon our existing tech-enabled solutions and provides our customers with access to a platform that aims to simplify prescription requests, allowing vet staff to devote more time to pet care.鈥�
About Wag! Group Co.
Wag! Group Co. strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household. Wag! pioneered on-demand dog walking in 2015 with the Wag! app, which offers access to 5-star dog walking, sitting, and one-on-one training from a community of over 500,000 Pet Caregivers nationwide. In addition, Wag! Group Co. operates Petted, one of the nation鈥檚 largest pet insurance comparison marketplaces; Dog Food Advisor, one of the most visited and trusted pet food review platforms; WoofWoofTV, a multi-media company bringing pet content to over 18 million followers across social media; and maxbone, a digital platform for modern pet essentials. For more information, visit .
About Furscription
Furscription is a digital tool designed to assist veterinarians and clinic staff streamline the prescription process. Furscription provides a secure, user-friendly software solution, and offers veterinarians access to a suite of features 鈥� including e-prescribing and prescription management tools 鈥� meant to enhance the prescribing experience and support efficient access to prescribed medications. For more information, visit .
About MWI Veterinary Supply Co.
MWI Veterinary Supply Co. is a leading global provider of veterinary products, services, and solutions that support the operations of veterinarians and animal healthcare. By combining local expertise with global reach, MWI Veterinary Supply Co. delivers innovative solutions that promote animal health and well-being. Learn more at .
Contact Us
Media:
Investor Relations
Wag!:
Gateway for Wag!:
FAQ
What did Wag! Group (PET) sell to MWI Veterinary Supply?
When did the Wag! Group Furscription sale close?
How will Wag! Group use the proceeds from the Furscription sale?
How many Wag! employees are transferring to MWI as part of the Furscription sale?
What is the strategic reason behind Wag! Group's sale of Furscription?
